Evan Alexander O'Donnell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroscopy | 8 | 2023 | 968 | 0.910 |
Why?
|
Bursitis | 1 | 2021 | 80 | 0.730 |
Why?
|
Tenodesis | 1 | 2021 | 50 | 0.720 |
Why?
|
Shoulder Joint | 3 | 2023 | 742 | 0.710 |
Why?
|
Rotator Cuff | 5 | 2023 | 348 | 0.640 |
Why?
|
Osteoarthritis | 2 | 2022 | 1060 | 0.570 |
Why?
|
Biological Products | 2 | 2023 | 912 | 0.560 |
Why?
|
Diabetes Complications | 1 | 2020 | 1315 | 0.430 |
Why?
|
Reoperation | 2 | 2020 | 4303 | 0.360 |
Why?
|
Anesthesia | 1 | 2021 | 1594 | 0.350 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3460 | 0.340 |
Why?
|
Collateral Ligaments | 2 | 2022 | 34 | 0.320 |
Why?
|
Elbow Joint | 2 | 2022 | 359 | 0.240 |
Why?
|
Telemedicine | 1 | 2022 | 3051 | 0.240 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2024 | 464 | 0.200 |
Why?
|
Acromioclavicular Joint | 1 | 2023 | 78 | 0.200 |
Why?
|
Joint Capsule Release | 1 | 2021 | 5 | 0.200 |
Why?
|
Baseball | 1 | 2022 | 95 | 0.190 |
Why?
|
Arthroplasty | 2 | 2021 | 313 | 0.190 |
Why?
|
Tenotomy | 1 | 2021 | 55 | 0.190 |
Why?
|
Shoulder | 1 | 2022 | 300 | 0.180 |
Why?
|
Range of Motion, Articular | 3 | 2021 | 1586 | 0.170 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 178 | 0.160 |
Why?
|
Postoperative Care | 2 | 2022 | 1471 | 0.160 |
Why?
|
Arm | 1 | 2021 | 590 | 0.150 |
Why?
|
Physical Therapy Modalities | 1 | 2021 | 532 | 0.150 |
Why?
|
Outpatients | 2 | 2023 | 1597 | 0.140 |
Why?
|
Knee Injuries | 1 | 2022 | 487 | 0.140 |
Why?
|
Tendons | 1 | 2021 | 558 | 0.140 |
Why?
|
Steroids | 1 | 2021 | 929 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 667 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2023 | 64651 | 0.130 |
Why?
|
Carcinoma, Embryonal | 1 | 2015 | 37 | 0.120 |
Why?
|
Medicare | 5 | 2024 | 6770 | 0.120 |
Why?
|
Hyperlipidemias | 1 | 2020 | 771 | 0.120 |
Why?
|
Prosthesis Design | 1 | 2022 | 2115 | 0.120 |
Why?
|
Joint Diseases | 1 | 2018 | 459 | 0.120 |
Why?
|
Seminoma | 1 | 2015 | 134 | 0.110 |
Why?
|
Retrospective Studies | 11 | 2024 | 80582 | 0.110 |
Why?
|
Orthopedics | 1 | 2021 | 897 | 0.100 |
Why?
|
Humans | 27 | 2024 | 761423 | 0.100 |
Why?
|
Comorbidity | 3 | 2024 | 10498 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2548 | 0.100 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1265 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2010 | 535 | 0.100 |
Why?
|
Osteoporosis | 1 | 2020 | 1605 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1386 | 0.090 |
Why?
|
Databases, Factual | 3 | 2020 | 7956 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 491 | 0.090 |
Why?
|
Pain | 2 | 2022 | 5071 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4244 | 0.080 |
Why?
|
Galectin 1 | 1 | 2010 | 128 | 0.080 |
Why?
|
Aged | 11 | 2024 | 169235 | 0.080 |
Why?
|
Ovulation | 1 | 2009 | 181 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 799 | 0.080 |
Why?
|
Menstruation Disturbances | 1 | 2009 | 143 | 0.080 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 226 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9645 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2497 | 0.070 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2010 | 305 | 0.070 |
Why?
|
Janus Kinase 2 | 1 | 2010 | 560 | 0.070 |
Why?
|
Joint Instability | 1 | 2014 | 801 | 0.070 |
Why?
|
Menstrual Cycle | 1 | 2009 | 539 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4946 | 0.070 |
Why?
|
Gene Dosage | 1 | 2010 | 1218 | 0.060 |
Why?
|
Patient Readmission | 3 | 2024 | 3269 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.050 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1378 | 0.050 |
Why?
|
United States | 7 | 2024 | 72339 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5840 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2010 | 1606 | 0.050 |
Why?
|
Risk Factors | 4 | 2023 | 74167 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Arthroplasty, Replacement | 1 | 2024 | 310 | 0.040 |
Why?
|
Rupture | 1 | 2022 | 443 | 0.040 |
Why?
|
Humerus | 1 | 2022 | 272 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1405 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4001 | 0.040 |
Why?
|
Computers | 1 | 2022 | 594 | 0.040 |
Why?
|
Menisci, Tibial | 1 | 2022 | 267 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41446 | 0.040 |
Why?
|
Middle Aged | 7 | 2024 | 220826 | 0.040 |
Why?
|
Muscles | 1 | 2023 | 1576 | 0.040 |
Why?
|
Upper Extremity | 1 | 2023 | 657 | 0.040 |
Why?
|
Back Pain | 1 | 2022 | 545 | 0.040 |
Why?
|
Length of Stay | 2 | 2022 | 6422 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9277 | 0.030 |
Why?
|
Male | 8 | 2024 | 360736 | 0.030 |
Why?
|
Postoperative Complications | 3 | 2024 | 15650 | 0.030 |
Why?
|
Female | 8 | 2024 | 392581 | 0.030 |
Why?
|
Adult | 6 | 2020 | 221148 | 0.030 |
Why?
|
Joint Capsule | 1 | 2014 | 68 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2328 | 0.030 |
Why?
|
Elbow | 1 | 2014 | 130 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23990 | 0.030 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2024 | 1411 | 0.030 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2024 | 1385 | 0.030 |
Why?
|
Exercise | 1 | 2009 | 5884 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8641 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58956 | 0.020 |
Why?
|
Ligaments, Articular | 1 | 2014 | 302 | 0.020 |
Why?
|
Pregnanediol | 1 | 2009 | 18 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10548 | 0.020 |
Why?
|
Oligomenorrhea | 1 | 2009 | 42 | 0.020 |
Why?
|
Anovulation | 1 | 2009 | 54 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 277 | 0.020 |
Why?
|
Luteal Phase | 1 | 2009 | 138 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 375 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2010 | 410 | 0.020 |
Why?
|
Estrone | 1 | 2009 | 234 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6238 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3357 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2009 | 820 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3589 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2010 | 651 | 0.020 |
Why?
|
Amenorrhea | 1 | 2009 | 483 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 682 | 0.020 |
Why?
|
Progesterone | 1 | 2009 | 742 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10203 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88313 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1125 | 0.020 |
Why?
|
Population Surveillance | 1 | 2015 | 2597 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2010 | 1393 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2010 | 16979 | 0.010 |
Why?
|
Sports | 1 | 2009 | 705 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6132 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12720 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2010 | 1588 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2821 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11106 | 0.010 |
Why?
|
Histones | 1 | 2010 | 2580 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39975 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2010 | 10441 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29620 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9418 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8545 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39117 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59207 | 0.000 |
Why?
|
Infant | 1 | 2010 | 36205 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 54415 | 0.000 |
Why?
|